Interactive tool · FDA label data
Drug Interaction Checker
Select two medications below to check for a known interaction, with severity, mechanism, and safety recommendations drawn from FDA drug labels.
- 3,919
- Interactions tracked
- 268
- Major (high-severity)
- 711
- Moderate
- 682
- Medications covered
Important: This tool is for informational purposes only. Always consult your healthcare provider or pharmacist before starting, stopping, or changing any medication.
Results: Nirmatrelvir/Ritonavir + Simvastatin
Description
HMG-CoA reductase inhibitors lovastatin, simvastatin ↑ lovastatin ↑ simvastatin Co-administration contraindicated due to potential for myopathy including rhabdomyolysis [see Contraindications (4) ] . If treatment with PAXLOVID is considered medically necessary, discontinue use of lovastatin and simvastatin at least 12 hours prior to initiation of PAXLOVID, during the 5 days of PAXLOVID treatment, and for 5 days after completing PAXLOVID.
Mechanism
This medicine stops your body from breaking down simvastatin, which can lead to high levels that cause serious muscle damage.
Recommendation
Stop taking simvastatin at least 12 hours before starting Paxlovid and do not start it again until 5 days after you finish the treatment.
Based on interactions documented in FDA drug labeling. Label-documented interactions are not exhaustive, so a pharmacist checking a full clinical interaction database may find more. This is informational, not a clinical decision.
What does "Major" severity mean?
Major interactions may be life-threatening or cause serious side effects. These drug combinations should generally be avoided. Talk to your doctor immediately if you are taking both medications.
Frequently Asked Questions
How does the drug interaction checker work?
What do the interaction severity levels mean?
What if no interaction is found?
Can I check more than two drugs at once?
Is this tool a substitute for medical advice?
Medical Disclaimer: This tool is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Drug interaction data is sourced from FDA drug labels and may not include all possible interactions. Always consult your doctor, pharmacist, or other qualified healthcare provider with any questions about your medications. Do not start, stop, or change any medication without professional medical advice.
Data source: U.S. Food and Drug Administration (FDA) drug labels via openFDA. The interaction set covers 3,919 documented drug-drug pairs across 682 medications, compiled from FDA Structured Product Labeling and last refreshed May 2026. See our methodology for source dates and how pairs are matched. Spot a pair that looks wrong? Report a correction.
Source: U.S. Food and Drug Administration (FDA): drug labels (Drug Interactions sections), Structured Product Labeling via openFDA. U.S. Food and Drug Administration (FDA): drug labels (Drug Interactions sections), Structured Product Labeling via openFDA.